Discordance With Local Guidelines for Adjuvant Chemotherapy in Breast Cancer: Reasons and Effect on Survival
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference20 articles.
1. Lost opportunities: physicians’ reasons and disparities in breast cancer treatment;Bickell;J Clin Oncol,2007
2. Discrepancy between consensus recommendations and actual community use of adjuvant chemotherapy in women with breast cancer;Du;Ann Intern Med,2003
3. Impact of breast cancer treatment guidelines on surgeon practice patterns: results of a hospital-based intervention;Mor;Surgery,2000
4. The difference between study recommendations, stated policy, and actual practice in a clinical trial;Goffin;Ann Oncol,2004
5. Physicians’ reasons for failing to deliver effective breast cancer care: a framework for underuse;Bickell;Med Care,2003
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The association between guideline adherence, age and overall survival among women with non-metastatic breast cancer: A systematic review;Cancer Treatment Reviews;2022-03
2. Impact of patients’ refusal to undergo adjuvant treatment measures on survival;Breast Cancer Research and Treatment;2020-09-24
3. Impact of deviation from guideline recommended treatment on breast cancer survival in Asia;Scientific Reports;2020-01-28
4. Time trends (2006–2015) of quality indicators in EUSOMA-certified breast centres;European Journal of Cancer;2017-11
5. Acceptance of adjuvant chemotherapy recommendations in early-stage hormone-positive breast cancer;Journal of Surgical Research;2017-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3